# OnCo record firicabtagene-autoleucel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/firicabtagene-autoleucel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "firicabtagene-autoleucel" ;
  schema:name "Firicabtagene autoleucel"@en ;
  schema:alternateName "CRG-022"@en, "firi-cel"@en ;
  schema:description "Firicabtagene autoleucel is an autologous CAR T-cell therapy from CARGO Therapeutics that reached phase 2 for relapsed or refractory large B-cell lymphoma; development has stopped."@en ;
  schema:url <https://onco.cc/drugs/firicabtagene-autoleucel/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1966494/000095017025066940/crgx-20250331.htm>, <https://www.sec.gov/Archives/edgar/data/1966494/000095017025066940/crgx-20250331.htm>, <https://clinicaltrials.gov/api/v2/studies/NCT05972720>, <https://clinicaltrials.gov/search?intr=CRG-022> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "discontinued" ;
  onco:modality "Autologous CAR T-cell therapy" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:targets <https://onco.cc/targets/cd22/> ;
  onco:companies <https://onco.cc/companies/cargo-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct05972720/> .